Company
Last deal
$90.M
Amount
Venture - Series Unknown
Stage
08.12.2023
Date
1
all rounds
$90.M
Total amount
General
About Company
Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating atrial fibrillation.
Industry
Keywords :
Also Known As
Cortex, Ablacon
founded date
2015
Number of employees
Company Type
For Profit
Last funding type
Venture - Series Unknown
IPO status
Private